BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 32597960)

  • 1. Remote ischaemic preconditioning ameliorates anthracycline-induced cardiotoxicity and preserves mitochondrial integrity.
    Galán-Arriola C; Villena-Gutiérrez R; Higuero-Verdejo MI; Díaz-Rengifo IA; Pizarro G; López GJ; Molina-Iracheta A; Pérez-Martínez C; García RD; González-Calle D; Lobo M; Sánchez PL; Oliver E; Córdoba R; Fuster V; Sánchez-González J; Ibanez B
    Cardiovasc Res; 2021 Mar; 117(4):1132-1143. PubMed ID: 32597960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronary microcirculation damage in anthracycline cardiotoxicity.
    Galán-Arriola C; Vílchez-Tschischke JP; Lobo M; López GJ; de Molina-Iracheta A; Pérez-Martínez C; Villena-Gutiérrez R; Macías Á; Díaz-Rengifo IA; Oliver E; Fuster V; Sánchez-González J; Ibanez B
    Cardiovasc Res; 2022 Jan; 118(2):531-541. PubMed ID: 33605403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the Changes in Cardiac Structure and Function in Mice Treated With Anthracyclines Using Serial Cardiac Magnetic Resonance Imaging.
    Farhad H; Staziaki PV; Addison D; Coelho-Filho OR; Shah RV; Mitchell RN; Szilveszter B; Abbasi SA; Kwong RY; Scherrer-Crosbie M; Hoffmann U; Jerosch-Herold M; Neilan TG
    Circ Cardiovasc Imaging; 2016 Dec; 9(12):. PubMed ID: 27923796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular magnetic resonance characterization of myocardial tissue injury in a miniature swine model of cancer therapy-related cardiovascular toxicity.
    Nakata K; Kucukseymen S; Cai X; Yankama T; Rodriguez J; Sai E; Pierce P; Ngo L; Nakamori S; Tung N; Manning WJ; Nezafat R
    J Cardiovasc Magn Reson; 2024 Summer; 26(1):101033. PubMed ID: 38460840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serial Magnetic Resonance Imaging to Identify Early Stages of Anthracycline-Induced Cardiotoxicity.
    Galán-Arriola C; Lobo M; Vílchez-Tschischke JP; López GJ; de Molina-Iracheta A; Pérez-Martínez C; Agüero J; Fernández-Jiménez R; Martín-García A; Oliver E; Villena-Gutierrez R; Pizarro G; Sánchez PL; Fuster V; Sánchez-González J; Ibanez B
    J Am Coll Cardiol; 2019 Feb; 73(7):779-791. PubMed ID: 30784671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of taurine against doxorubicin-induced cardiotoxicity in rats: echocardiographical and histological findings.
    Barış VÖ; Gedikli E; Yersal N; Müftüoğlu S; Erdem A
    Amino Acids; 2019 Nov; 51(10-12):1649-1655. PubMed ID: 31673792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MMP inhibitors attenuate doxorubicin cardiotoxicity by preventing intracellular and extracellular matrix remodelling.
    Chan BYH; Roczkowsky A; Cho WJ; Poirier M; Sergi C; Keschrumrus V; Churko JM; Granzier H; Schulz R
    Cardiovasc Res; 2021 Jan; 117(1):188-200. PubMed ID: 31995179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring effects of remote ischemic preconditioning in a pig model of hypothermic circulatory arrest.
    Herajärvi J; Anttila T; Dimova EY; Laukka T; Myllymäki M; Haapanen H; Olenchock BA; Tuominen H; Puistola U; Karihtala P; Kiviluoma K; Koivunen P; Anttila V; Juvonen T
    Scand Cardiovasc J; 2017 Aug; 51(4):233-241. PubMed ID: 28434264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remote Ischemic Pre-Conditioning Attenuates Adverse Cardiac Remodeling and Mortality Following Doxorubicin Administration in Mice.
    Gertz ZM; Cain C; Kraskauskas D; Devarakonda T; Mauro AG; Thompson J; Samidurai A; Chen Q; Gordon SW; Lesnefsky EJ; Das A; Salloum FN
    JACC CardioOncol; 2019 Dec; 1(2):221-234. PubMed ID: 32699841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of doxorubicin-induced Cardiotoxicity by pharmacological non-hypoxic myocardial preconditioning based on Docosahexaenoic Acid (DHA) and carvedilol direct antioxidant effects: study protocol for a pilot, randomized, double-blind, controlled trial (CarDHA trial).
    Carrasco R; Ramirez MC; Nes K; Schuster A; Aguayo R; Morales M; Ramos C; Hasson D; Sotomayor CG; Henriquez P; Cortés I; Erazo M; Salas C; Gormaz JG
    Trials; 2020 Feb; 21(1):137. PubMed ID: 32019575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrahigh-field cardiovascular magnetic resonance T1 and T2 mapping for the assessment of anthracycline-induced cardiotoxicity in rat models: validation against histopathologic changes.
    Park HS; Hong YJ; Han K; Kim PK; An E; Lee JY; Park CH; Lee HJ; Hur J; Kim YJ; Choi BW
    J Cardiovasc Magn Reson; 2021 Jun; 23(1):76. PubMed ID: 34134713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exercise and Doxorubicin Treatment Modulate Cardiac Mitochondrial Quality Control Signaling.
    Marques-Aleixo I; Santos-Alves E; Torrella JR; Oliveira PJ; Magalhães J; Ascensão A
    Cardiovasc Toxicol; 2018 Feb; 18(1):43-55. PubMed ID: 28536949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for
    Chakouri N; Farah C; Matecki S; Amedro P; Vincenti M; Saumet L; Vergely L; Sirvent N; Lacampagne A; Cazorla O
    Theranostics; 2020; 10(18):8130-8142. PubMed ID: 32724462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noncontrast CMR for Detecting Early Myocardial Tissue Injury in a Swine Model of Anthracycline-Induced Cardiotoxicity.
    Nakamori S; Jang J; Tschabrunn CM; Pierce P; Goddu B; Rodriguez J; Ngo LH; Tung NM; Manning WJ; Nezafat R
    JACC Cardiovasc Imaging; 2019 Oct; 12(10):2085-2087. PubMed ID: 31202765
    [No Abstract]   [Full Text] [Related]  

  • 15. Myocardial triggers involved in activation of remote ischaemic preconditioning.
    Donato M; Goyeneche MA; Garces M; Marchini T; Pérez V; Del Mauro J; Höcht C; Rodríguez M; Evelson P; Gelpi RJ
    Exp Physiol; 2016 Jun; 101(6):708-16. PubMed ID: 27028009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin.
    Quagliariello V; De Laurentiis M; Rea D; Barbieri A; Monti MG; Carbone A; Paccone A; Altucci L; Conte M; Canale ML; Botti G; Maurea N
    Cardiovasc Diabetol; 2021 Jul; 20(1):150. PubMed ID: 34301253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the parasympathetic nervous system in cardioprotection by remote hindlimb ischaemic preconditioning.
    Donato M; Buchholz B; Rodríguez M; Pérez V; Inserte J; García-Dorado D; Gelpi RJ
    Exp Physiol; 2013 Feb; 98(2):425-34. PubMed ID: 22872660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of intermittent lower limb ischaemia on coronary blood flow and coronary resistance in pigs.
    Shimizu M; Konstantinov IE; Kharbanda RK; Cheung MH; Redington AN
    Acta Physiol (Oxf); 2007 Jun; 190(2):103-9. PubMed ID: 17394577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anthracycline cardiotoxicity: an update on mechanisms, monitoring and prevention.
    Henriksen PA
    Heart; 2018 Jun; 104(12):971-977. PubMed ID: 29217634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcutaneous electrical nerve stimulation as a novel method of remote preconditioning: in vitro validation in an animal model and first human observations.
    Merlocco AC; Redington KL; Disenhouse T; Strantzas SC; Gladstone R; Wei C; Tropak MB; Manlhiot C; Li J; Redington AN
    Basic Res Cardiol; 2014 May; 109(3):406. PubMed ID: 24604614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.